Literature DB >> 25870038

Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation.

Maoyi Lai1, Changchun Xiao2.   

Abstract

The miR-17-92 cluster is a prototypical example of a polycistronic miRNA gene. Recently, miR-17-92 has emerged as a pleiotropic regulator in immune system. Its loss or deregulation leads to defects in lymphocyte development and response, and lymphoma development. Although the six individual miRNAs of the cluster are expressed together from the same primary transcript, their relative abundance, functional contributions and interactions vary in different cellular contexts.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cells; Lymphoma; T cells; miR-17–92; miRNA clusters; microRNAs

Mesh:

Substances:

Year:  2015        PMID: 25870038      PMCID: PMC4586290          DOI: 10.1016/j.intimp.2015.03.041

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  57 in total

1.  A microRNA cluster as a target of genomic amplification in malignant lymphoma.

Authors:  H Tagawa; M Seto
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

Review 2.  The protean nature of cells in the B lymphocyte lineage.

Authors:  Richard R Hardy; Paul W Kincade; Kenneth Dorshkind
Journal:  Immunity       Date:  2007-06       Impact factor: 31.745

Review 3.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

4.  Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.

Authors:  Michael Dews; Asal Homayouni; Duonan Yu; Danielle Murphy; Cinzia Sevignani; Erik Wentzel; Emma E Furth; William M Lee; Greg H Enders; Joshua T Mendell; Andrei Thomas-Tikhonenko
Journal:  Nat Genet       Date:  2006-07-30       Impact factor: 38.330

5.  The expression and significance of miR-17-92 cluster miRs in CD4+ T cells from patients with systemic lupus erythematosus.

Authors:  Hai Hong Qin; Xiao Hua Zhu; Jun Liang; Jin Feng Wu; Yong Sheng Yang; Jin Hua Xu
Journal:  Clin Exp Rheumatol       Date:  2013-02-22       Impact factor: 4.473

6.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.

Authors:  Yoji Hayashita; Hirotaka Osada; Yoshio Tatematsu; Hideki Yamada; Kiyoshi Yanagisawa; Shuta Tomida; Yasushi Yatabe; Katsunobu Kawahara; Yoshitaka Sekido; Takashi Takahashi
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

8.  The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a.

Authors:  Sonia Guil; Javier F Cáceres
Journal:  Nat Struct Mol Biol       Date:  2007-06-10       Impact factor: 15.369

9.  The microRNA cluster miR-17∼92 promotes TFH cell differentiation and represses subset-inappropriate gene expression.

Authors:  Dirk Baumjohann; Robin Kageyama; Jonathan M Clingan; Malika M Morar; Sana Patel; Dimitri de Kouchkovsky; Oliver Bannard; Jeffrey A Bluestone; Mehrdad Matloubian; K Mark Ansel; Lukas T Jeker
Journal:  Nat Immunol       Date:  2013-06-30       Impact factor: 25.606

10.  MicroRNAs of the miR-17∼92 family are critical regulators of T(FH) differentiation.

Authors:  Seung Goo Kang; Wen-Hsien Liu; Peiwen Lu; Hyun Yong Jin; Hyung W Lim; Jovan Shepherd; Daniel Fremgen; Eric Verdin; Michael B A Oldstone; Hai Qi; John R Teijaro; Changchun Xiao
Journal:  Nat Immunol       Date:  2013-06-30       Impact factor: 25.606

View more
  5 in total

1.  MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.

Authors:  Yongxia Wu; Steven Schutt; Katelyn Paz; Mengmeng Zhang; Ryan P Flynn; David Bastian; M Hanief Sofi; Hung Nguyen; Min Dai; Chen Liu; Ying-Jun Chang; Bruce R Blazar; Xue-Zhong Yu
Journal:  Blood       Date:  2018-03-12       Impact factor: 22.113

2.  Differential Sensitivity of Target Genes to Translational Repression by miR-17~92.

Authors:  Hyun Yong Jin; Hiroyo Oda; Pengda Chen; Chao Yang; Xiaojuan Zhou; Seung Goo Kang; Elizabeth Valentine; Jennifer M Kefauver; Lujian Liao; Yaoyang Zhang; Alicia Gonzalez-Martin; Jovan Shepherd; Gareth J Morgan; Tony S Mondala; Steven R Head; Pyeung-Hyeun Kim; Nengming Xiao; Guo Fu; Wen-Hsien Liu; Jiahuai Han; James R Williamson; Changchun Xiao
Journal:  PLoS Genet       Date:  2017-02-27       Impact factor: 5.917

3.  miR-18a increases insulin sensitivity by inhibiting PTEN.

Authors:  Yongqiang Zhou; Ruoqi Wu; Huafang Su; Kejie Li; Chun Chen; Raoying Xie
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

4.  Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs.

Authors:  Sara Bozzini; Claudia Del Fante; Monica Morosini; Hatice Oya Berezhinskiy; Sophia Auner; Elena Cattaneo; Matteo Della Zoppa; Laura Pandolfi; Rosalia Cacciatore; Cesare Perotti; Konrad Hoetzenecker; Peter Jaksch; Alberto Benazzo; Federica Meloni
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600

5.  NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Maren Kaufmann; Roderick A F MacLeod; Hans G Drexler
Journal:  Oncotarget       Date:  2017-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.